Products for Research Use Only
RegisterLogin

CDK9-IN-39

CAT: 0931-T211204-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T211204-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
Apoptosis, CDK
Related Pathways
Cell Cycle/Checkpoint, Apoptosis
Bioactivity
CDK9-IN-39 (1-7a-B1) is an orally active inhibitor of cyclin-dependent kinase 9 (CDK9), with an IC50 value of 6.51 nM. By inhibiting the phosphorylation of RNA polymerase II at the Ser2 site, CDK9-IN-39 induces cell (apoptosis) and can be used for colorectal cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T204890-01CDK2-IN-39
T205526-01CDK9-IN-36
T201179-01CDK9-IN-35
T10742-01CDK9-IN-10
T10746-01CDK9-IN-8
T63490-01CDK9-IN-19
T79630-01CDK9-IN-25
T79037-01CDK9-IN-23
T10743-01CDK9-IN-11
T206913-01CDK9-IN-38

Alternative Products

CatalogName
GTR19263601-01CDK9-IN-39
030081CDK9
GTR18308618CDK9-55/CDK9 Rabbit Polyclonal Antibody
BA3838-50CDK9-IN-10
BA3826-1CDK9-IN-13
BA2986-1CDK9-IN-7
BA3853-10CDK9-IN-14
HY-173481CDK9-IN-37
HY-130852-01CDK9-IN-11
70R-10466CDK9 antibody

Popular Products